1864003-48-4 Usage
Uses
Used in Pharmaceutical Synthesis:
(2S,4R)-Benzyl 4-hydroxypyrrolidine-2-carboxylate hydrochloride is used as an intermediate in the pharmaceutical industry for the synthesis of various biologically active compounds. Its unique structure, including the benzyl group and functional groups, makes it a valuable building block for creating novel drugs with potential therapeutic applications.
Used in Drug Delivery Systems:
In the field of drug delivery, (2S,4R)-benzyl 4-hydroxypyrrolidine-2-carboxylate hydrochloride can be utilized as a component in the development of targeted drug delivery systems. Its hydroxyl and carboxylic acid functional groups can be exploited to enhance the compound's interaction with specific biological targets, potentially improving the efficacy and selectivity of drug delivery.
Used in Chemical Research:
(2S,4R)-Benzyl 4-hydroxypyrrolidine-2-carboxylate hydrochloride is also used as a research tool in chemical and biological laboratories. Its chiral nature and functional groups make it an interesting subject for studying the effects of stereochemistry on compound-receptor interactions and the development of enantioselective synthetic methods.
Check Digit Verification of cas no
The CAS Registry Mumber 1864003-48-4 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,8,6,4,0,0 and 3 respectively; the second part has 2 digits, 4 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 1864003-48:
(9*1)+(8*8)+(7*6)+(6*4)+(5*0)+(4*0)+(3*3)+(2*4)+(1*8)=164
164 % 10 = 4
So 1864003-48-4 is a valid CAS Registry Number.
1864003-48-4Relevant academic research and scientific papers
(4-HYDROXYPYRROLIDIN-2-YL)-HYDROXAMATE COMPOUNDS AND METHODS OF USE THEREOF
-
Paragraph 0632, (2019/05/15)
The present disclosure relates to bifunctional compounds, which can be used as modulators of targeted ubiquitination. In particular, the present disclosure is directed to compounds which contain on one end a VHL ligand moiety, which binds to the VHL E3 ubiquitin ligase, and on the other end a moiety that binds a target protein such that degradation of the target protein/polypeptide is effectuated. Also disclosed are VHL ligands.
